This double-blind, single-centre placebo controlled, bilateral (split-face) comparative study was undertaken
during the winter of 2010-2011 in Chengdu, China. The study protocol was reviewed and approved by a local
ethics committee. Informed consent and photography consent were obtained from each subject before enrollment.